Loading...
XSHE
002462
Market cap635mUSD
Dec 05, Last price  
15.40CNY
1D
0.00%
1Q
10.55%
IPO
-0.52%
Name

Cachet Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002462 chart
P/E
27.96
P/S
0.19
EPS
0.55
Div Yield, %
1.69%
Shrs. gr., 5y
2.27%
Rev. gr., 5y
1.60%
Revenues
24.02b
-19.93%
662,903,001965,221,7981,133,559,8451,341,671,1341,801,380,2392,554,073,3033,544,275,1675,572,152,3398,199,831,90810,971,576,55714,238,899,71617,959,885,46622,186,572,87423,256,135,89125,625,618,76926,219,790,24429,996,240,36124,018,607,695
Net income
161m
-35.75%
182,625,34341,356,80742,418,31248,542,36963,682,54965,209,640130,168,774228,060,085172,976,469223,099,559263,641,638327,633,235659,802,381590,903,501601,878,580468,312,507250,060,041160,668,362
CFO
180m
-88.70%
054,833,05150,116,113-49,607,20848,574,6100000116,304,01300293,114,5561,114,869,517913,127,42301,595,439,529180,355,187
Dividend
Jun 27, 20240.26 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cachet Pharmaceutical Co., Ltd. engages in the wholesale and retail sale of pharmaceutical products in China. It is involved in the supply of medicines to hospitals; wholesale of biological products, medical instruments, and traditional Chinese medicines; pharmaceutical logistic operations; and manufacture of medicines. The company owns 150 chain stores in Beijing that sell medicines, health care foods, medical instruments, cosmetics, daily necessities, and traditional Chinese medicines. Cachet Pharmaceutical Co., Ltd. was founded in 1998 and is based in Beijing, China.
IPO date
Aug 18, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT